ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 315,000
-11,500 (-3.52%)
Jun 10, 2026, 3:30 PM KST
ALTEOGEN Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 203,761 | 215,859 | 102,855 | 96,523 | 28,806 | 38,746 |
Other Revenue | 0 | - | - | - | -0 | - |
| 203,761 | 215,859 | 102,855 | 96,523 | 28,806 | 38,746 | |
Revenue Growth (YoY) | 34.36% | 109.87% | 6.56% | 235.08% | -25.65% | -8.67% |
Cost of Revenue | 47,759 | 50,261 | 38,813 | 65,382 | 24,352 | 33,045 |
Gross Profit | 156,002 | 165,598 | 64,041 | 31,141 | 4,454 | 5,701 |
Selling, General & Admin | 20,015 | 17,370 | 12,748 | 14,466 | 14,232 | 12,714 |
Research & Development | 46,465 | 37,048 | 24,550 | 25,306 | 18,660 | 7,480 |
Amortization of Goodwill & Intangibles | 2,896 | 2,892 | 191.45 | 164.25 | 117.16 | 95.06 |
Other Operating Expenses | 701.17 | 679.65 | 511.85 | 337.76 | 319.91 | 221.69 |
Operating Expenses | 70,819 | 58,698 | 38,637 | 40,878 | 33,828 | 20,893 |
Operating Income | 85,183 | 106,900 | 25,404 | -9,737 | -29,374 | -15,192 |
Interest Expense | -12,763 | -10,967 | -674.94 | -670.88 | -425.48 | -604.66 |
Interest & Investment Income | 12,685 | 11,207 | 7,819 | 5,298 | 3,869 | 2,066 |
Earnings From Equity Investments | -20.35 | -26.63 | - | - | - | - |
Currency Exchange Gain (Loss) | 8,931 | -2,279 | 7,055 | 230.33 | 1,691 | 2,971 |
Other Non Operating Income (Expenses) | 89,692 | 57,219 | -3,156 | 1,196 | 3,026 | -11,700 |
EBT Excluding Unusual Items | 183,708 | 162,054 | 36,447 | -3,683 | -21,213 | -22,460 |
Gain (Loss) on Sale of Investments | 768.88 | 692.63 | 24.59 | 31.23 | 11,360 | 13,310 |
Gain (Loss) on Sale of Assets | -14.26 | -10.52 | - | 109.96 | 127.41 | -18.48 |
Asset Writedown | -39.09 | - | -14.97 | -22.17 | -527.51 | -1,525 |
Other Unusual Items | - | - | 155.01 | - | 282.58 | - |
Pretax Income | 184,424 | 162,736 | 36,612 | -3,564 | -9,970 | -10,694 |
Income Tax Expense | 50,944 | 17,563 | -24,078 | 17.83 | 108.05 | 893.17 |
Earnings From Continuing Operations | 133,479 | 145,173 | 60,690 | -3,582 | -10,078 | -11,588 |
Minority Interest in Earnings | -3,293 | -3,507 | 1,562 | 210.44 | 1,932 | 5,313 |
Net Income | 130,187 | 141,666 | 62,252 | -3,372 | -8,146 | -6,275 |
Net Income to Common | 130,189 | 141,666 | 62,252 | -3,372 | -8,146 | -6,275 |
Net Income Growth | 4.60% | 127.57% | - | - | - | - |
Shares Outstanding (Basic) | 53 | 53 | 53 | 52 | 51 | 51 |
Shares Outstanding (Diluted) | 54 | 54 | 54 | 52 | 51 | 51 |
Shares Change (YoY) | 0.99% | 0.82% | 3.62% | 0.74% | 1.32% | 0.54% |
EPS (Basic) | 2435.78 | 2652.97 | 1172.04 | -65.27 | -158.85 | -123.98 |
EPS (Diluted) | 1960.14 | 2591.24 | 1163.00 | -65.27 | -159.00 | -124.00 |
EPS Growth | -15.66% | 122.81% | - | - | - | - |
Free Cash Flow | 113,947 | 101,121 | 50,326 | -8,985 | -24,298 | -23,046 |
Free Cash Flow Per Share | 2106.77 | 1873.74 | 940.15 | -173.92 | -473.81 | -455.33 |
Dividend Per Share | 371.000 | 371.000 | - | - | - | - |
Gross Margin | 76.56% | 76.72% | 62.26% | 32.26% | 15.46% | 14.71% |
Operating Margin | 41.80% | 49.52% | 24.70% | -10.09% | -101.97% | -39.21% |
Profit Margin | 63.89% | 65.63% | 60.52% | -3.49% | -28.28% | -16.20% |
Free Cash Flow Margin | 55.92% | 46.85% | 48.93% | -9.31% | -84.35% | -59.48% |
EBITDA | 92,912 | 112,390 | 28,254 | -6,403 | -26,719 | -13,041 |
EBITDA Margin | 45.60% | 52.07% | 27.47% | -6.63% | -92.75% | -33.66% |
D&A For EBITDA | 7,728 | 5,489 | 2,850 | 3,334 | 2,654 | 2,151 |
EBIT | 85,183 | 106,900 | 25,404 | -9,737 | -29,374 | -15,192 |
EBIT Margin | 41.80% | 49.52% | 24.70% | -10.09% | -101.97% | -39.21% |
Effective Tax Rate | 27.62% | 10.79% | - | - | - | - |
Advertising Expenses | - | 568.18 | 218.22 | 21.68 | 4.51 | 16.78 |